MYCOSIS FUNGOIDES
Clinical trials for MYCOSIS FUNGOIDES explained in plain language.
Never miss a new study
Get alerted when new MYCOSIS FUNGOIDES trials appear
Sign up with your email to follow new studies for MYCOSIS FUNGOIDES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Light-Activated ointment shows promise for rare skin cancer
Disease control CompletedThis study tested a synthetic ointment (HyBryte) activated by visible light to treat mycosis fungoides, a type of skin lymphoma. Ten adults with early-stage disease received treatment for up to 54 weeks. The goal was to see if the ointment could reduce redness, scaling, and plaqu…
Matched conditions: MYCOSIS FUNGOIDES
Phase: PHASE2 • Sponsor: Ellen Kim, MD • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New hope for rare lymphoma: targeted drug shows promise in small trial
Disease control CompletedThis completed Phase 4 trial tested the drug brentuximab vedotin in 10 Chinese adults with a rare type of skin lymphoma called CD30-positive cutaneous T-cell lymphoma. The goal was to see if the drug could shrink or eliminate cancer for at least 4 months and to check for long-ter…
Matched conditions: MYCOSIS FUNGOIDES
Phase: PHASE4 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 26, 2026 18:32 UTC
-
Light therapy restores immune balance in rare skin cancer
Knowledge-focused CompletedThis study looked at 16 people with mycosis fungoides, a rare skin lymphoma, and 16 healthy volunteers. Researchers measured a protein called IL-35, which can suppress the immune system, in blood and skin samples before and after phototherapy (light treatment). They found that IL…
Matched conditions: MYCOSIS FUNGOIDES
Phase: NA • Sponsor: Kasr El Aini Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC